We are powering science and medicine to improve health by decoding the unknown.
Location: United States, Utah, Salt Lake City
Employees: 51-200
Total raised: $29M
Founded date: 2014
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 29.01.2020 | Series B | $20M | - |
| 08.09.2016 | Series A | $9M | - |
Persons 5
| Date | First Name | Last Name | Title | Location | |||
| - | Wan | Xie | Principal ... | linkedin.c... | - | w**e@idbyd... | - |
| - | Kate | Broadbent | Director, ... | linkedin.c... | - | k********t... | - |
| - | Dina | Hannah | - | linkedin.c... | - | d*****h@id... | - |
| - | Steven | Flygare | VP of Tech... | linkedin.c... | - | s******e@i... | - |
| - | Aurélie | Kapusta | Bioinforma... | linkedin.c... | - | a******a@i... | - |
Mentions in press and media 14
| Date | Title | Description |
| 13.10.2021 | IDbyDNA Expands Scientific Advisory Board with Infectious Disease, Sequencing & FDA Leaders | The promise and power of IDbyDNA’s approach to democratizing Precision Metagenomics has never been more evident, and we are delighted to welcome these esteemed leaders to our Scientific Advisory Board. SAN FRANCISCO (PRWEB) October 13, 2021... |
| 16.06.2021 | IDbyDNA to Present Three Seminars at World Microbe Forum | The global health community is coming together like never before and we’re thrilled to bring our expertise in metagenomics and antimicrobial resistance (AMR) to the discussion. SAN FRANCISCO (PRWEB) June 16, 2021 Today, IDbyDNA, the company... |
| 05.05.2021 | IDbyDNA Appoints Next-Gen Sequencing Executive Neil Gunn as New CEO | The need for rapid identification of the cause of infectious disease at the genetic level has never been more apparent than it is today. SAN FRANCISCO (PRWEB) May 05, 2021 Infectious disease continues to be a leading cause of illness, morbi... |
| 09.04.2021 | IDbyDNA Shares Insights on Role of Metagenomics for Tracking COVID-19 on New Illumina Podcast | Medicine is on the cusp of the most dramatic change in infectious disease work since the discovery of antibiotics. SAN FRANCISCO (PRWEB) April 09, 2021 Today, IDbyDNA, the company revolutionizing the use of metagenomics to improve health by... |
| 23.03.2021 | IDbyDNA Boosts Its Global Metagenomic Respiratory Pathogen/AMR Surveillance Solution to Now Offer Enhanced SARS-CoV-2 Variant Interpretation | The key to managing COVID-19, influenza, and other emerging respiratory infections, is more robust and real-time genomic-level insights into circulating strains. SAN FRANCISCO (PRWEB) March 23, 2021 As the battle against COVID-19 rages on, ... |
| 08.02.2021 | IDbyDNA’s Leading Medical Experts to Speak on Respiratory Pathogen Detection via Precision Metagenomics at Illumina Webinar | IDbyDNA worked with Illumina to develop a new Respiratory ID/AMR Panel workflow and automated data analysis solution that simultaneously detects 300+ respiratory pathogens and nearly 1200 AMR markers in under 24 hours. SAN FRANCISCO (PRWEB)... |
| 15.01.2021 | The Future Is Now: How Metagenomics Could Affect Infectious Disease Diagnostics | Co-Founder & CEO of IDbyDNA, the company revolutionizing the use of metagenomics to improve health by decoding the unknown. |
| 14.01.2021 | IDbyDNA Announces Engagement in United States Defense Advanced Research Projects Agency (DARPA) Program to Detect Threats using Gene Editing Technologies | "Now more than ever, the world — and particularly, the Department of Defense (DoD) — is in need of innovative solutions that can better identify pathogens and mitigate the spread of disease and other health threats." SAN FRANCISCO... |
| 01.12.2020 | IDbyDNA Receives Accreditation from College of American Pathologists (CAP) | “The value of an accreditation from CAP cannot be overstated for strengthening our positioning within our scientific community, as well as the business community and investors." SAN FRANCISCO (PRWEB) December 01, 2020 The Accreditation... |
| 29.01.2020 | IDbyDNA Raises $20M in Series B Financing | IDbyDNA, Inc., a San Francisco, CA-based metagenomics technology company, raised $20m in Series B financing. The round was led by Artis Ventures with participation from Genesys Capital and others. The company intends to use the funds to acc... |
Show more